WallStreetZenWallStreetZen

NASDAQ: MGRX
Mangoceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

MGRX past revenue growth

How has MGRX's revenue growth performed historically?
Company
8,083.16%
Industry
11.91%
Market
17.55%
MGRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MGRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MGRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MGRX earnings and revenue history

Current Revenue
$731.5k
Current Earnings
-$9.2M
Current Profit Margin
-1,259.4%

MGRX Return on Equity

Current Company
-411.7%
Current Industry
-0.2%
Current Market
188.7%
MGRX's Return on Equity (-411.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MGRX announces earnings.

MGRX Return on Assets

Current Company
-366.4%
Current Industry
0.8%
MGRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MGRX Return on Capital Employed

Current Company
-1,097.09%
Current Industry
2.2%

MGRX vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MGRX$731.49k-$9.19M-$9.21M+8,083.16%N/A
HCTI$33.20M-$4.10M-$12.34M+3.68%N/A
ZCMD$17.23M-$7.22M-$7.76M+37.68%N/A
WORX$3.92M-$1.66M-$1.67M+8.29%N/A
FOXO$453.00k-$67.02M-$73.13M+70.41%N/A
View Top Health Information Service Stocks

Mangoceuticals Earnings & Revenue FAQ

What were MGRX's earnings last quarter?

Mangoceuticals (NASDAQ: MGRX) reported Q4 2023 earnings per share (EPS) of -$0.12, up 100% year over year. Total Mangoceuticals earnings for the quarter were -$2.57 million. In the same quarter last year, Mangoceuticals's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Mangoceuticals stock.

What was MGRX's earnings growth in the past year?

As of Q2 2024, Mangoceuticals's earnings has grown year over year. Mangoceuticals's earnings in the past year totalled -$9.21 million.

What was MGRX's revenue last quarter?

Mangoceuticals (NASDAQ: MGRX) reported Q4 2023 revenue of $244.37 thousand up 2,633.8% year over year. In the same quarter last year, Mangoceuticals's revenue was $8.94 thousand.

What was MGRX's revenue growth in the past year?

As of Q2 2024, Mangoceuticals's revenue has grown 8,083.16% year over year. This is 8,071.25 percentage points higher than the US Health Information Services industry revenue growth rate of 11.91%. Mangoceuticals's revenue in the past year totalled $731.49 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.